Division Faculty


Jaquelyn F. Fleckenstein, M.D.

Jaquelyn F. Fleckenstein, M.D.

Associate Professor of Medicine

Medical School

St. Louis University School of Medicine, St. Louis, MO (1985)

Residency

University of Michigan Hospitals

Fellowship

Gastroenterology, The Johns Hopkins University
Transplantation Hepatology, The Johns Hopkins University

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine, Gastroenterology

Clinical Interest

Hepatology

Research Interest

Differences in HCV response to therapy between Caucasians and African-Americans.

Selected Publications

  1. Fleckenstein JF, Frank S, Thuluvath PJ. 1996. "Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease." Hepatology 23(3): 471-5.
  2. Fleckenstein JF, Paredes M, Thuluvath PJ. 1998. A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection. Liver Transpl Surg. 4(4): 276-9.
  3. Demirkan K, Fleckenstein JF. 2000. Thrombocytopenia associated with octreotide. Am J Med Sci 320(4):296-297.
  4. Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network. 2003. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 98(9): 2060-3.
  5. Fleckenstein, J. 2004. Chronic hepatitis C in african americans and other minority groups. Curr Gastroenterol Rep. 2004 Feb; 6(1): 66-70.
  6. Castellino S. Lensing S. Riely C. Rai SN. Davila R. Hayden RT. Fleckenstein J. Levstik M. Taylor S. Dean PJ. Kippenbrock S. Pope J. Carr J. Strickland DK. Hudson MM. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood. 2004;103:2460-6.
  7. Park VM, Mason BC, Krushkal J, Li R, Riely C, Fleckenstein J. Hepatitis C Hypervariable Region 1: Association of Reduced Selection Pressure in African Americans with Treatment Failure. Dig Dis Sci.2007;52: 2540-2549.
  8. Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008; 48:1769-78.
  9. Pheffer LM, Madey MA, Riely CA, Fleckenstein JF. The induction of type I interferon production in hepatitis C-infected patients. J Interferon Cytokine Res. 2009; 29: 299-306.

Selected Book Chapter

  1. Fleckenstein J, Diehl AM:   Complications of Chronic Liver Disease In Current Diagnosis and Treatment in Gastroenterology, Grendell, McQuaid and Friedman, editors, Stamford, CT, 1996, pp. 558-570.
Gastro instrument endoscope

Contact Us

Division of Gastroenterology and Hepatology
956 Court Ave, Suite H314
Memphis, TN 38163
Phone: 901-448-2510
Fax: 901-448-7836
Site contact: Donna Heath

A division of the
Department of Internal Medicine